Data / Form D filings / Droplet Biosciences, Inc.
Droplet Biosciences, Inc.: Form D filings
Droplet Biosciences, Inc., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on December 13, 2023, reports $7.6 million sold of a $14.1 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 750 Main Street, Cambridge, MA, 02139
- Phone
- (832) 622-8454
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1847243
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | New notice | $14,113,973 | $7,613,974 | $6,499,999 | 21 | Nov 28, 2023 | sec.gov |
| May 28, 2021 | New notice | $5,348,980 | $5,348,980 | 30 | May 21, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rachel Sha | Director | |
| Stanley Lapidus | Director | |
| Theresa Tribble | Executive Officer, Director | |
| Ann DeWitt | Director | |
| Jose Zevallos | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 11, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Droplet Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.